Amneal Pharmaceuticals AMRX reported its Q2 earnings results on Friday, August 5, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
Amneal Pharmaceuticals missed estimated earnings by 5.0%, reporting an EPS of $0.19 versus an estimate of $0.2.
Revenue was up $24.28 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.01 which was followed by a 4.83% drop in the share price the next day.
Here's a look at Amneal Pharmaceuticals's past performance:
|Quarter||Q1 2022||Q4 2021||Q3 2021||Q2 2021|
To track all earnings releases for Amneal Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.